Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 3
1978 5
1979 4
1980 1
1981 4
1982 6
1983 3
1984 3
1985 6
1986 5
1987 7
1988 7
1989 6
1990 7
1991 4
1992 11
1993 9
1994 9
1995 14
1996 21
1997 14
1998 12
1999 18
2000 14
2001 14
2002 17
2003 15
2004 16
2005 18
2006 21
2007 9
2008 18
2009 53
2010 130
2011 180
2012 237
2013 246
2014 259
2015 304
2016 260
2017 308
2018 359
2019 160
2020 13
Text availability
Article attribute
Article type
Publication date

Search Results

2,486 results
Results by year
Filters applied: . Clear all
Page 1
Biological Role and Therapeutic Potential of IDH Mutations in Cancer.
Waitkus MS, Diplas BH, Yan H. Waitkus MS, et al. Cancer Cell. 2018 Aug 13;34(2):186-195. doi: 10.1016/j.ccell.2018.04.011. Epub 2018 May 24. Cancer Cell. 2018. PMID: 29805076 Free PMC article. Review.
Molecular Pathways: Isocitrate Dehydrogenase Mutations in Cancer.
Clark O, Yen K, Mellinghoff IK. Clark O, et al. Clin Cancer Res. 2016 Apr 15;22(8):1837-42. doi: 10.1158/1078-0432.CCR-13-1333. Epub 2016 Jan 27. Clin Cancer Res. 2016. PMID: 26819452 Free PMC article. Review.
Isocitrate Dehydrogenase Genes.
Tsamaloukas A. Tsamaloukas A. Dtsch Arztebl Int. 2015 May 25;112(21-22):372. doi: 10.3238/arztebl.2015.0372a. Dtsch Arztebl Int. 2015. PMID: 26149376 Free PMC article. No abstract available.
Isocitrate Dehydrogenase 1 Expression in Canine Gliomas.
Fraser AR, Bacci B, le Chevoir MA, Long SN. Fraser AR, et al. J Comp Pathol. 2018 Nov;165:33-39. doi: 10.1016/j.jcpa.2018.09.005. Epub 2018 Oct 20. J Comp Pathol. 2018. PMID: 30502793
Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer.
Wu F, Cheng G, Yao Y, Kogiso M, Jiang H, Li XN, Song Y. Wu F, et al. Med Chem. 2018;14(7):715-724. doi: 10.2174/1573406414666180524093659. Med Chem. 2018. PMID: 29792149 Free PMC article.
Therapeutic targeting of isocitrate dehydrogenase mutant AML.
Boddu P, Borthakur G. Boddu P, et al. Expert Opin Investig Drugs. 2017 May;26(5):525-530. doi: 10.1080/13543784.2017.1317745. Epub 2017 Apr 19. Expert Opin Investig Drugs. 2017. PMID: 28388242 No abstract available.
The clinical use of IDH1 and IDH2 mutations in gliomas.
Picca A, Berzero G, Di Stefano AL, Sanson M. Picca A, et al. Expert Rev Mol Diagn. 2018 Dec;18(12):1041-1051. doi: 10.1080/14737159.2018.1548935. Epub 2018 Nov 29. Expert Rev Mol Diagn. 2018. PMID: 30427756 Free article. Review.
2,486 results
Jump to page
Feedback